In early May 2022 it was announced that BICO (formerly CELLINK and an early SBIR Awardee in its own right) had acquired all the shares in San Diego-based Allegro 3D Inc. for an up-front enterprise value of USD 6 million. Further, it was reported, that shareholders will potentially receive USD 5 million in an earn-out payment contingent on Allegro 3D's financial performance inthe two years following acquisition. The entire purchase price will be paid in cash. An emerging 3D printing and bio printing company Allegro 3D had been indicated as at the convergence of advanced additive manufacturing, stem cell biology and biomaterials, Allegro 3Dâs expertise in bioprinting and biomaterials enables high-throughput manufacturing of advanced biomedical devices, cell matrices and precision human tissues for cell culture, drug screening, therapeutics and regenerative medicine. Using the most advanced bioprinting technologies developed at the University of California San Diego, Allegro 3D has been structured to provide customers with transformational biofabrication solutions that will revolutionize healthcare innovations related to regenerative medicine, drug discovery, and biomedical research.
